Compound brief
Semax
Evidence brief. Not treatment advice or a safety clearance. Last evidence update: September 2026.
What researchers are studying it for
Met-Glu-His-Phe-Pro-Gly-Pro. Related to an ACTH fragment, not to amphetamine. Nasal discussion dominates forums. A human stimulant-equivalence trial is not in this seed.
An ACTH fragment is not a catecholamine releaser.
Pathway
ACTH fragments can influence attention and melanocortin signaling. Semax adds the Pro-Gly-Pro tail. BDNF expression shows up in preclinical discussion.
Dopamine-system forum claims should not be upgraded to amphetamine chemistry. The molecule does not reverse the dopamine transporter.
Forum themes
Forum themes are unverified. They do not outrank a study, and they are not a dose.
No forum theme is stored for this compound.